CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Grant or award Director acquired 59,701 shares (grant or award)
- 4 Grant or award Director acquired 59,701 shares (grant or award)
- 4 Grant or award Director acquired 59,701 shares (grant or award)
- 4 Grant or award Director acquired 59,701 shares (grant or award)
- 4 Grant or award Director acquired 59,701 shares (grant or award)
- 4 Grant or award Director acquired 59,701 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 251,889 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 7,500 shares at $3.69 ($27,638)
- 4 Shares withheld for taxes Chief Commerical Officer gave up 55,975 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,069 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 946 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,019 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,055 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 549 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technology Officer gave up 22,310 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 14,683 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 37,799 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 5,995 shares (to pay taxes)
- 4 Grant or award Chief Commerical Officer acquired 226,804 shares (grant or award)
Page 2 of 65 · 1,293 filings